| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301529A1 Hydroxymethylbutyrate compositions and uses thereof |
| 03/30/2011 | EP2300008A1 Supplementation of propane-1,2,3-triol and water in fasting subjects |
| 03/30/2011 | EP2299998A1 Medium-chain length fatty acids and glycerides as nephroprotection agents |
| 03/30/2011 | EP2299997A2 Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| 03/30/2011 | EP1948216B1 Treatment of acute renal failure with soluble thrombomodulin |
| 03/30/2011 | EP1829536B1 Ameliorant for renal insufficiency |
| 03/30/2011 | EP1775289B1 Novel imidazolidine derivatives |
| 03/30/2011 | CN101998966A Methods of using cadherin 11 (CDH11) antagonists |
| 03/30/2011 | CN101998957A Substituted xanthine derivatives |
| 03/30/2011 | CN101991840A Method for preparing prostate cancer-resisting mussel enzymolytic extract and application thereof |
| 03/30/2011 | CN101991799A Medicine for treating nephritis |
| 03/30/2011 | CN101991772A Traditional Chinese medicine health-care tea with function of tonifying kidney-yin and kidney-yang |
| 03/30/2011 | CN101991759A Traditional Chinese medicine granule formula for treating prostatitis and preparation method |
| 03/30/2011 | CN101991758A Formula of traditional Chinese medicine particle for treating benign prostatic hyperplasia and preparation method thereof |
| 03/30/2011 | CN101991757A Chinese medicinal composition for reinforcing kidney and supporting yang and preparation method thereof |
| 03/30/2011 | CN101991755A Traditional Chinese medicine composition for treating kidney deficiency |
| 03/30/2011 | CN101991746A Formula and preparation method of traditional Chinese medicinal grains for treating prostatoplasia and prostatauxe |
| 03/30/2011 | CN101991700A Traditional Chinese medicine for treating chronic prostatitis |
| 03/30/2011 | CN101991698A Medicinal food product for dissipating and removing stone and preparation method |
| 03/30/2011 | CN101991681A Traditional Chinese medicine for treating benign prostatic hyperplasia |
| 03/30/2011 | CN101991678A Application of India madder root in preparing medicine for preventing and treating kidney disease |
| 03/30/2011 | CN101991654A Navel applying medicament for treating infantile enuresis |
| 03/30/2011 | CN101991642A Walnut ointment preparation method |
| 03/30/2011 | CN101991633A Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof |
| 03/30/2011 | CN101991597A Applications of oral pharmaceutical composition to preparation of medicament for preventing or treating kidney diseases |
| 03/30/2011 | CN101991575A Application of evodiamine in preparing medicine for inhibiting aryl hydrocarbon receptor |
| 03/30/2011 | CN101991570A Stable compound keto acid preparation and preparation method thereof |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101990971A Method for preparing Indian buead persimmon leaf tea |
| 03/30/2011 | CN101406535B Chinese medicinal decoction for treating urinary lithiasis |
| 03/30/2011 | CN101375988B Anti-inflammation formulation for treating acute prostatitis and preparation method thereof |
| 03/30/2011 | CN101283968B Tolterodine fumarate oral solid preparation and preparation method thereof |
| 03/30/2011 | CN101229275B Compounds used for tonifying the kidney, nourishing the liver and preparing method thereof |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists |
| 03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/29/2011 | CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 03/24/2011 | WO2011035110A2 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2010058227A3 NOVEL USES OF VEGFxxxB |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071225 Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071204 Percutaneous absorption preparation |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071192 Therapeutic Agents Useful for Treating Pain |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071146 17BetaHSD Type 5 Inhibitor |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |
| 03/24/2011 | US20110071085 Use of survivin to treat kidney failure |
| 03/24/2011 | US20110070280 Method for differentiating embryonic stem cells into cells expressing aqp-1 |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | CA2774239A1 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298767A1 Nitrogenated bicyclic heterocyclic compound |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2296648A1 Naphthylmethylimidizoles for the treatment of stress urinary incontinence |
| 03/23/2011 | EP1983990B1 A3 adenosine receptor allosteric modulators |
| 03/23/2011 | EP1330444B1 Nitrogenous heterocyclic compounds and process for making them |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | EP1140836B1 Amide compounds |
| 03/23/2011 | CN1951372B Solid oral dosage forms comprising valsartan and HCTZ |
| 03/23/2011 | CN1785249B Novel use of medicine composition containing red-rooted salvia |
| 03/23/2011 | CN101987187A Formula of Chinese herbal medicine for treating lithiasis |
| 03/23/2011 | CN101987162A Traditional Chinese medical preparation for treating anaphylatic purpura nephritis nephrotic syndrome |
| 03/23/2011 | CN101987139A Traditional Chinese medicine for treating diabetic nephropathy |
| 03/23/2011 | CN101987130A Traditional Chinese medicine compound preparation for treating early hypertension kidney damage |
| 03/23/2011 | CN101987086A Ultra-fine bicalutamide oral tablet and preparation method thereof |
| 03/23/2011 | CN101856457B Medicine with kidney tonifying, essence replenishing and yang invigorating functions and preparation method thereof |
| 03/23/2011 | CN101693090B Technology for preparing compound kidney inflammation tablets |
| 03/23/2011 | CN101658655B Traditional Chinese medicine for treating liver-kidney diseases |
| 03/23/2011 | CN101391007B Preparation method of soft-capsule of saw palmetto fruit extract |
| 03/23/2011 | CN101385841B Traditional Chinese medicine for treating urgent, chronic nephropyeltis |
| 03/23/2011 | CN101229350B Chinese traditional medicine for treating prostatitis |
| 03/23/2011 | CN101199803B Oral administration Chinese medicine for treating wean enuresis |
| 03/23/2011 | CN101175751B Crystal of indole derivative having piperidine ring and process for production thereof |
| 03/23/2011 | CN101129394B New use of aesculin in preventing and/or treating cardiovascular disease |
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
| 03/22/2011 | US7910593 Water-soluble prodrugs |
| 03/22/2011 | CA2487238C Hydroxy tetrahydro-naphthalenylurea derivatives |